Lionshead Wealth Management LLC Decreases Stock Holdings in UnitedHealth Group Incorporated $UNH

Lionshead Wealth Management LLC trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 20.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 568 shares of the healthcare conglomerate’s stock after selling 146 shares during the quarter. Lionshead Wealth Management LLC’s holdings in UnitedHealth Group were worth $297,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Marshall & Sterling Wealth Advisors Inc. bought a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $26,000. Bayforest Capital Ltd raised its holdings in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd raised its holdings in UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 50 shares during the period. Kapitalo Investimentos Ltda bought a new stake in UnitedHealth Group during the 4th quarter valued at $41,000. Finally, Copia Wealth Management bought a new stake in UnitedHealth Group during the 4th quarter valued at $42,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $307.0980 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a 50-day moving average of $288.39 and a 200-day moving average of $389.57. The firm has a market cap of $278.13 billion, a P/E ratio of 13.31, a P/E/G ratio of 1.96 and a beta of 0.43. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the firm’s stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares of the company’s stock, valued at $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.28% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of analyst reports. Royal Bank Of Canada lowered their target price on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Wolfe Research decreased their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating on the stock in a report on Tuesday, May 20th. KeyCorp decreased their price target on shares of UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a report on Wednesday, July 30th. Raymond James Financial cut shares of UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a report on Wednesday, May 14th. Finally, Robert W. Baird reaffirmed an “underperform” rating and issued a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Fifteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $365.38.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.